Related Experiment Videos
Utilization of antiparkinsonian drugs in Sweden, 1974-1987
P Hartvig1, O Gudjónsson, S M Aquilonius
1Department of Neurology, University Hospital, Uppsala, Sweden.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
V-RISK-10: validation of a screen for risk of violence after discharge from acute psychiatry.
European psychiatry : the journal of the Association of European Psychiatrists·2010
The first step in the validation of a new screen for violence risk in acute psychiatry: The inpatient context.
European psychiatry : the journal of the Association of European Psychiatrists·2010
Development of a brief screen for violence risk (V-RISK-10) in acute and general psychiatry: An introduction with emphasis on findings from a naturalistic test of interrater reliability.
European psychiatry : the journal of the Association of European Psychiatrists·2009
Objective assessment of cervical dystonia: a pilot study.
Acta neurologica Scandinavica·2005
Positron emission tomography and brain monoamine neurotransmission -- entries for study of drug interactions.
Current pharmaceutical design·2002
Duodenal levodopa infusion in Parkinson's disease--long-term experience.
Acta neurologica Scandinavica·2002
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
A Multicenter, Prospective Real-World Study of Simethicone-Activated Charcoal in Patients With Persistent Dyspeptic Symptoms Despite Acid Suppression (SIMAC Study).
JGH open : an open access journal of gastroenterology and hepatology·2026
A Re-Appraisal of Three Network Meta-Analyses to Explain the Discrepancy in Findings for the Efficacy of Fluoxetine for the Treatment of Depression in Children and Adolescents.
Cochrane evidence synthesis and methods·2026